There is seems to be a breakthrough against the current global pandemic, as the coronavirus vaccine could be available to give in the form of an inhaler by next month according to a report.
Trials of a vaccine being developed by Oxford University are currently ongoing with the initial target of September to be available to the public.
Drug company Astra Zeneca has stated it will produce the vaccine light so it’s ready when final approval is given and intends to produce two billion doses thanks to funding from Microsoft billionaire Bill Gates.
The Oxford University team are reportedly “80 per cent confident” the Covid-19 vaccine work in younger people and say the vaccine could be given using a device like an asthma inhaler next month.
The news came in an online lecture for Oxford University’s Centre for Personalised Medicine given by team member Professor Adrian Hill, the Daily Mail reports.
He revealed that the clinical trials will end when the vaccine has clearly been found to protect people.
“We are guessing that might be around about August time – it might be before if cases do not decline as quickly as we expect, or be later if we run out of cases,” he revealed.
The Oxford trial began back in April and began recruiting up to 10,260 adults over 55 and children.
AstraZeneca has already agreed to supply 100 million doses of the potential vaccine to the UK.
It has also signed a massive $1 billion deal for a coronavirus vaccine with the U.S government.
The Anglo-Swedish firm will supply 400 million doses of the Covid-19 drug currently being developed by the University of Oxford.
The drug is still undergoing trials at the university’s Jenner Institute, which is working with the Oxford Vaccine Group on the project.
The order from US Biomedical Advanced Research and Development Authority comes after demands for from Donald Trump for a coronavirus vaccine by the end of the year, as part of program dubbed ‘Operation Warp Speed’.
There is no vaccine or treatment available for the virus but doctors around the world are testing current anti-viral drugs to see if they can deal coronavirus.
Coronavirus since its outbreak from the Chinese city of Wuhan in December 31 2019, has killed more than 300,000 people while over 4 million people have been affected globally.
rials of a vaccine being developed by Oxford University are currently ongoing with the initial target of September to be available to the public.